219 related articles for article (PubMed ID: 18216090)
1. Hepatitis C virus inhibits cell surface expression of HLA-DR, prevents dendritic cell maturation, and induces interleukin-10 production.
Saito K; Ait-Goughoulte M; Truscott SM; Meyer K; Blazevic A; Abate G; Ray RB; Hoft DF; Ray R
J Virol; 2008 Apr; 82(7):3320-8. PubMed ID: 18216090
[TBL] [Abstract][Full Text] [Related]
2. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
Ohno Y; Kitamura H; Takahashi N; Ohtake J; Kaneumi S; Sumida K; Homma S; Kawamura H; Minagawa N; Shibasaki S; Taketomi A
Cancer Immunol Immunother; 2016 Feb; 65(2):193-204. PubMed ID: 26759006
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.
Kim H; Mazumdar B; Bose SK; Meyer K; Di Bisceglie AM; Hoft DF; Ray R
J Virol; 2012 Sep; 86(18):9919-28. PubMed ID: 22761382
[TBL] [Abstract][Full Text] [Related]
4. Role of A20 in interferon-α-mediated functional restoration of myeloid dendritic cells in patients with chronic hepatitis C.
Ma L; Zhou Y; Zhang Y; Li Y; Guo Y; He Y; Wang J; Lian J; Hao C; Moorman JP; Yao ZQ; Zhou Y; Jia Z
Immunology; 2014 Dec; 143(4):670-8. PubMed ID: 24965710
[TBL] [Abstract][Full Text] [Related]
5. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells.
Barth H; Ulsenheimer A; Pape GR; Diepolder HM; Hoffmann M; Neumann-Haefelin C; Thimme R; Henneke P; Klein R; Paranhos-Baccalà G; Depla E; Liang TJ; Blum HE; Baumert TF
Blood; 2005 May; 105(9):3605-14. PubMed ID: 15657184
[TBL] [Abstract][Full Text] [Related]
6. Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.
Sandhu PK; Buchkovich NJ
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915281
[TBL] [Abstract][Full Text] [Related]
7. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals.
Kanto T; Hayashi N; Takehara T; Tatsumi T; Kuzushita N; Ito A; Sasaki Y; Kasahara A; Hori M
J Immunol; 1999 May; 162(9):5584-91. PubMed ID: 10228041
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.
Kang W; Sung PS; Park SH; Yoon S; Chang DY; Kim S; Han KH; Kim JK; Rehermann B; Chwae YJ; Shin EC
Gastroenterology; 2014 May; 146(5):1351-60.e1-4. PubMed ID: 24486950
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
[TBL] [Abstract][Full Text] [Related]
10. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.
Yonkers NL; Rodriguez B; Milkovich KA; Asaad R; Lederman MM; Heeger PS; Anthony DD
J Immunol; 2007 Apr; 178(7):4436-44. PubMed ID: 17372001
[TBL] [Abstract][Full Text] [Related]
11. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
[TBL] [Abstract][Full Text] [Related]
12. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
14. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
[TBL] [Abstract][Full Text] [Related]
15. Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA.
Pan H; O'Brien TF; Wright G; Yang J; Shin J; Wright KL; Zhong XP
J Immunol; 2013 Jul; 191(2):699-707. PubMed ID: 23776173
[TBL] [Abstract][Full Text] [Related]
16. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
17. HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation.
Tu Z; Hamalainen-Laanaya HK; Nishitani C; Kuroki Y; Crispe IN; Orloff MS
Int Immunol; 2012 Feb; 24(2):97-106. PubMed ID: 22190574
[TBL] [Abstract][Full Text] [Related]
18. Differential dysfunction in dendritic cell subsets during chronic HCV infection.
Averill L; Lee WM; Karandikar NJ
Clin Immunol; 2007 Apr; 123(1):40-9. PubMed ID: 17239662
[TBL] [Abstract][Full Text] [Related]
19. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function.
Shiina M; Rehermann B
Hepatology; 2008 Feb; 47(2):385-95. PubMed ID: 18064579
[TBL] [Abstract][Full Text] [Related]
20. HCV J6/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines.
Fang Z; Zhu K; Guo N; Zhang N; Guan M; Yang C; Pan Q; Wei R; Yang C; Deng C; Liu X; Zhao P; Leng Q
Pharm Res; 2015 Mar; 32(3):741-8. PubMed ID: 23619596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
